MAS1L and Hepatic fibrosis: Numerous studies document the beneficial effects of the ACE2/Ang (1-7)/MASR axis in the liver, such as improvements in steatosis and non-alcoholic inflammation, liver fibrosis, and insulin sensitivity [59].